As of November 2024, Arovella Therapeutics has a market cap of $77.01M. This makes Arovella Therapeutics the world's 21295th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $86.64M | 56.52% |
2023 | $55.35M | 400.00% |
2022 | $11.07M | -41.03% |
2021 | $18.77M | -2.50% |
2020 | $19.25M | -18.60% |
2019 | $23.65M | -59.30% |
2018 | $58.11M | -59.09% |
2017 | $142.05M | -15.79% |
2016 | $168.69M | -29.63% |
2015 | $239.71M | -54.24% |
2014 | $523.82M | -24.36% |
2013 | $692.50M | 129.41% |
2012 | $301.86M | 61.90% |
2011 | $186.44M | -58.82% |
2010 | $452.79M | -32.00% |
2009 | $665.87M | 2.89% |
2008 | $647.13M | -54.44% |
2007 | $1.42B | 44.00% |
2006 | $986.48M | 0.00% |
2005 | $986.48M | -44.44% |
2004 | $1.78B | -52.94% |
2003 | $3.77B | 145.20% |
2002 | $1.54B | - |